Jacopo Uliano
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 03, 2024
Fast Mimicking Diets and Other Innovative Nutritional Interventions to Treat Patients with Breast Cancer.
Journal: Cancer treatment and research
Published: January 04, 2024
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target.
Journal: Cancers
Published: August 11, 2023
Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.
Journal: The oncologist
Published: December 19, 2022
Targeting HER3 for cancer treatment: a new horizon for an old target.
Journal: ESMO open
Published: November 24, 2022
Combination immunotherapy strategies for triple-negative breast cancer: current progress and barriers within the pharmacological landscape.
Journal: Expert review of clinical pharmacology
Published: November 01, 2022
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 09, 2022
Systemic Treatment of Ductal Carcinoma In Situ of the Breast.
Journal: Chirurgia (Bucharest, Romania : 1990)
Published: December 01, 2021
Clinical development and current role of margetuximab for the treatment of breast cancer.
Journal: Drugs of today (Barcelona, Spain : 1998)
Published: September 29, 2021
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review.
Journal: Breast cancer research and treatment
Published: March 15, 2021
First line treatment of BRAF mutated advanced melanoma: Does one size fit all?
Journal: Cancer treatment reviews
Published: February 02, 2021
Margetuximab for the treatment of HER2-positive metastatic breast cancer.
Journal: Expert opinion on biological therapy
Published: November 26, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026